Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers.
Pettus LH, Bourbeau M, Tamayo NA, Amegadzie A, Beylkin D, Booker SK, Butler J, Frohn MJ, Kaller MR, Kohn T, Lanman BA, Li K, Liu Q, Ma V, Medina J, Minatti AE, Lopez P, Manoni F, Pickrell A, Weires N, Andersson J, Cowland S, Glad S, Sarvary I, Vestergaard M, Li W, Ghimire-Rijal S, Mardirossian N, Mukund S, Chen Q, Lo MC, Ngo R, Khetan J, Madoux F, Sanders C, Sharma P, Wang P, Bruenner B, McCloud S, Ponce M, Soto M, Wahlstrom J, Xie F, Yang Y, Liu S, Tan H, Policheni A, Caenepeel S, Slemmons KK, Belmontes B, Hughes P, Allen JR.
Pettus LH, et al. Among authors: ma v.
J Med Chem. 2025 Apr 10;68(7):6932-6954. doi: 10.1021/acs.jmedchem.4c03121. Epub 2025 Mar 27.
J Med Chem. 2025.
PMID: 40146197
Clinical Trial.